AHMED Et Al.
ꢀꢁꢀ ꢀ 9 of 10
|
ꢀ
ꢀ
6.ꢀ Mégraudꢀ F,ꢀ Occhialiniꢀ A,ꢀ Rossignolꢀ JF.ꢀ Nitazoxanide,ꢀ aꢀ poten-
tial drug for eradication of Helicobacter pylori with no cross-
resistanceꢀ toꢀ metronidazole.ꢀ Antimicrob Agents Chemother.
ꢀ2 5.ꢀ Tominagaꢀ H,ꢀ Ishiyamaꢀ M,ꢀ Ohsetoꢀ F,ꢀ etꢀ al.ꢀ Aꢀ water- ꢀs olubleꢀ tetra-
zoliumꢀsaltꢀusefulꢀforꢀcolorimetricꢀcellꢀviabilityꢀassay.ꢀAnal Commun.
1999;36(2):47- ꢀ5 0.
ꢀ2 6.ꢀ MosmannꢀT.ꢀRapidꢀcolorimetricꢀassayꢀforꢀcellularꢀgrowthꢀandꢀsur-
vival: application to proliferation and cytotoxicity assays. J Immunol
Methods.ꢀ1 9 8 3 ; 6 5 ( 1 - ꢀ2 ) :5 5 - ꢀ6 3 .
ꢀ2 7.ꢀ BermanꢀHM,ꢀWestbrookꢀJ,ꢀFengꢀZ.ꢀTheꢀproteinꢀdataꢀbank,ꢀ1999.ꢀIn:ꢀ
RossmannꢀMG,ꢀArnoldꢀE,ꢀeds.ꢀInternational Tables for Crystallography
Volume F: Crystallography of Biological Macromolecules. Netherlands:
Springer;ꢀ2006:675- ꢀ6 84.
28. Kim S, Thiessen PA, Bolton EE, et al. PubChem substance and com-
pound databases. Nucleic Acids Res.ꢀ2015;44(D1):D1202- ꢀD 1213.
ꢀ2 9.ꢀ Knoxꢀ C,ꢀ Lawꢀ V,ꢀ Jewisonꢀ T,ꢀ etꢀ al.ꢀ Drugꢀ Bankꢀ 3.0:ꢀ aꢀ comprehen-
siveꢀ resourceꢀ forꢀ ‘omics’ꢀ researchꢀ onꢀ drugs.ꢀ Nucleic Acids Res.
2010;39(suppl_1):D1035- ꢀD 1041.
1998;42(11):2836- ꢀ2 840.
7.ꢀ McVayꢀ CS,ꢀ Rolfeꢀ RD.ꢀ Inꢀ vitroꢀ andꢀ inꢀ vivoꢀ activitiesꢀ ofꢀ ni-
8.ꢀ BaileyꢀMA,ꢀNaꢀH,ꢀDuthieꢀMS,ꢀGillisꢀTP,ꢀLahiriꢀR.ꢀParishꢀTꢀnitazoxanideꢀisꢀ
9.ꢀ RossignolꢀJF,ꢀAbu- ꢀZ ekryꢀM,ꢀHusseinꢀA,ꢀSantoroꢀMG.ꢀEffectꢀofꢀnitazox-
anide for treatment of severe rotavirus diarrhoea: randomised double-
blind placebo-controlled trial. Lancet.ꢀ2006;368(9530):124- ꢀ1 29.
ꢀ
ꢀ
ꢀ
10.ꢀ RossignolꢀJF.ꢀNitazoxanide:ꢀaꢀfirst- ꢀi n- cꢀ lassꢀbroad- ꢀs ectrumꢀantiviralꢀ
agent. Antiviral Res.ꢀ2014;110:94- ꢀ1 03.
11.ꢀ WangꢀM,ꢀCaoꢀR,ꢀZhangꢀL,ꢀetꢀal.ꢀRemdesivirꢀandꢀchloroquineꢀeffec-
ꢀ3 0.ꢀ DundasꢀJ,ꢀOuyangꢀZ,ꢀTsengꢀJ,ꢀBinkowskiꢀA,ꢀTurpazꢀY,ꢀLiangꢀJ.ꢀCASTp:ꢀ
computed atlas of surface topography of proteins with structural
and topographical mapping of functionally annotated residues.
Nucleic Acids Res.ꢀ2006;34(suppl_2):W116- ꢀW 118.
ꢀ
tivelyꢀinhibitꢀtheꢀrecentlyꢀemergedꢀnovelꢀcoronavirusꢀ(2019- ꢀn CoV)ꢀ
in vitro. Cell Res.ꢀ2020;30(3):269- ꢀ2 71.
ꢀ
12.ꢀ KelleniꢀMT.ꢀNitazoxanide/azithromycinꢀcombinationꢀforꢀCOVID- ꢀ1 9:ꢀ
13.ꢀ Hossainꢀ MJ,ꢀ Rahmanꢀ SMA.ꢀ Repurposingꢀ therapeuticꢀ agentsꢀ
ꢀ3 1.ꢀ VolkamerꢀA,ꢀKuhnꢀD,ꢀRippmannꢀF,ꢀRareyꢀM.ꢀDoGSiteScorer:ꢀaꢀwebꢀ
server for automatic binding site prediction, analysis and druggabil-
ity assessment. Bioinformatics.ꢀ2012;28(15):2074- ꢀ2 075.
ꢀ3 2.ꢀ MorrisꢀGM,ꢀGoodsellꢀDS,ꢀHallidayꢀRS.ꢀAutomatedꢀdockingꢀusingꢀaꢀ
Lamarckian genetic algorithm and an empirical binding free energy
function. J Comput Chem.ꢀ1998;19(14):1639- ꢀ1 662.
ꢀ3 3.ꢀ O'Boyleꢀ NM,ꢀ Banckꢀ M,ꢀ Jamesꢀ CA,ꢀ Morleyꢀ C,ꢀ Vandermeerschꢀ
T, Hutchison GR. Open Babel: an open chemical toolbox. J
Cheminformatics.ꢀ2011;3(1):33.
ꢀ3 4.ꢀ TrottꢀO,ꢀOlsonꢀAJ.ꢀAutoDockꢀVina:ꢀimprovingꢀtheꢀspeedꢀandꢀaccu-
racyꢀofꢀdockingꢀwithꢀaꢀnewꢀscoringꢀfunction,ꢀefficientꢀoptimization,ꢀ
and multithreading. J Comput Chem.ꢀ2010;31(2):455- ꢀ4 61.
ꢀ3 5.ꢀ HardingꢀSD,ꢀSharmanꢀJ,ꢀFaccendaꢀE,ꢀetꢀal.ꢀTheꢀIUPHAR/BPSꢀGuideꢀ
toꢀPHARMACOLOGYꢀinꢀ2019:ꢀupdatesꢀandꢀexpansionꢀtoꢀencom-
ꢀ3 6.ꢀ Alexanderꢀ SPH,ꢀ Kellyꢀ E,ꢀ Mathieꢀ A,ꢀ etꢀ al.ꢀ Theꢀ Conciseꢀ guideꢀ toꢀ
2
ꢀ
against SARS-CoV-2 infection: most promising and neoteric
ꢀ1 4.ꢀ Navarrete- ꢀV azquezꢀ G,ꢀ Chávez- ꢀS ilvaꢀ F,ꢀ Argotte- ꢀR amosꢀ R,ꢀ etꢀ al.ꢀ
Synthesisꢀofꢀbenzologuesꢀofꢀnitazoxanideꢀandꢀtizoxanide:ꢀaꢀcompar-
ativeꢀstudyꢀofꢀtheirꢀinꢀvitroꢀbroad- ꢀs pectrumꢀantiprotozoalꢀactivity.ꢀ
Bioorg Med Chem Lett.ꢀ2011;21(10):3168- ꢀ3 171.
ꢀ1 5.ꢀ SciorꢀT,ꢀLozano- ꢀA ponteꢀJ,ꢀAjmaniꢀS,ꢀetꢀal.ꢀAntiprotozoalꢀnitazoxa-
nide derivatives: synthesis, bioassays and QSAR study combined
with docking for mechanistic insight. Curr Comput Aided Drug Des.
2
015;11(1):21- ꢀ3 1.
ꢀ1 6.ꢀ Soria- ꢀA rtecheꢀ O,ꢀ Hernández- ꢀC amposꢀ A,ꢀ Yépez- ꢀM uliaꢀ L,ꢀ
etꢀ al.ꢀ Synthesisꢀ andꢀ antiprotozoalꢀ activityꢀ ofꢀ nitazoxanide–ꢀ
N- ꢀm ethylbenzimidazoleꢀ hybrids.ꢀ Bioorg Med Chem Lett.
2
013;23(24):6838- 6ꢀ 841.
1
7. Ballard TE, Wang X, Olekhnovich I, et al. Biological activity of mod-
ifiedꢀ andꢀ exchangedꢀ 2- ꢀa mino- ꢀ5 - nꢀ itrothiazoleꢀ amideꢀ analoguesꢀ ofꢀ
nitazoxanide.ꢀBioorg Med Chem Lett.ꢀ2010;20(12):3537- ꢀ3 539.
ꢀ1 8.ꢀ GauꢀJS,ꢀLinꢀWP,ꢀKuoꢀLC,ꢀHuꢀMK.ꢀNitazoxanideꢀ analoguesꢀ asꢀan-
ꢀ3 8.ꢀ Baumannꢀ E.ꢀ Ueberꢀ eineꢀ einfacheꢀ Methodeꢀ derꢀ Darstellungꢀ vonꢀ
ꢀ
19.ꢀ Jeankumarꢀ VU,ꢀ Chandranꢀ M,ꢀ Samalaꢀ G,ꢀ etꢀ al.ꢀ Developmentꢀ ofꢀ
ꢀ3 9.ꢀ Sisonꢀ G,ꢀ Goodwinꢀ A,ꢀ Raudonikieneꢀ A,ꢀ etꢀ al.ꢀ Enzymesꢀ associatedꢀ
withꢀ reductiveꢀ activationꢀ andꢀ actionꢀ ofꢀ nitazoxanide,ꢀ nitrofu-
rans,ꢀ andꢀ metronidazoleꢀ inꢀ Helicobacter pylori. Antimicrob Agents
Chemother.ꢀ2002;46(7):2116- ꢀ2 123.
5
- ꢀn itrothiazoleꢀderivatives:ꢀidentificationꢀofꢀleadsꢀagainstꢀbothꢀrep-
licativeꢀandꢀlatentꢀMycobacteriumꢀtuberculosis.ꢀBioorg Med Chem
Lett.ꢀ2012;22(24):7414- ꢀ7 417.
ꢀ
20.ꢀ StachulskiꢀAV,ꢀSantoroꢀMG,ꢀPiacentiniꢀS,ꢀetꢀal.ꢀSecond- ꢀg enerationꢀ
40. Di Santo N, Ehrisman J. Research perspective: potential role of ni-
tazoxanideꢀ inꢀovarianꢀ cancerꢀ treatment.ꢀ Oldꢀdrug,ꢀnewꢀpurpose?ꢀ
Cancers.ꢀ2013;5(3):1163- ꢀ1 176.
nitazoxanideꢀderivatives:ꢀthiazolidesꢀareꢀeffectiveꢀinhibitorsꢀofꢀtheꢀ
influenzaꢀAꢀvirus.ꢀFuture Med Chem.ꢀ2018;10(8):851- ꢀ8 62.
2
1. Ballard TE, Wang X, Olekhnovich I, et al. Synthesis and antimi-
crobialꢀ evaluationꢀ ofꢀ nitazoxanide- ꢀb asedꢀ analogues:ꢀ identifica-
tion of selective and broad spectrum activity. ChemMedChem.
ꢀ4 1.ꢀ SenkowskiꢀW,ꢀZhangꢀX,ꢀOlofssonꢀMH,ꢀetꢀal.ꢀThree- ꢀd imensionalꢀcellꢀ
culture- ꢀb asedꢀscreeningꢀidentifiesꢀtheꢀanthelminticꢀdrugꢀnitazoxa-
nide as a candidate for treatment of colorectal cancer. Mol Cancer
Ther.ꢀ2015;14(6):1504- ꢀ1 516.
ꢀ4 2.ꢀ YuꢀJ,ꢀYangꢀK,ꢀZhengꢀJ,ꢀetꢀal.ꢀSynergisticꢀtumorꢀinhibitionꢀofꢀcolonꢀ
2
011;6(2):362- ꢀ3 77.
22.ꢀ BauerꢀAW,ꢀKirbyꢀWMM,ꢀSherrisꢀJC,ꢀTurckꢀM.ꢀAntibioticꢀsuscepti-
bilityꢀtestingꢀbyꢀaꢀstandardizedꢀsingleꢀdiskꢀmethod.ꢀAm J Clin Path.
966;45(4_ts):493- ꢀ4 96.
23.ꢀ Stroberꢀ W.ꢀ Trypanꢀ blueꢀ dyeꢀ exclusionꢀ testꢀ ofꢀ cellꢀ viability.ꢀ Curr
ꢀ
1
ꢀ
24.ꢀ IshiyamaꢀM,ꢀMiyazonoꢀY,ꢀSasamotoꢀK,ꢀOhkuraꢀY,ꢀUenoꢀK.ꢀAꢀhighlyꢀ
ꢀ4 3.ꢀ DiꢀSantoꢀN,ꢀEhrismanꢀJ.ꢀAꢀfunctionalꢀperspectiveꢀofꢀnitazoxanideꢀasꢀ
a potential anticancer drug. Mutat Res.ꢀ2014;768:16- ꢀ2 1.
ꢀ4 4.ꢀ ColeꢀJC,ꢀMurrayꢀCW,ꢀNissinkꢀJWM,ꢀTaylorꢀRD,ꢀTaylorꢀR.ꢀComparingꢀ
protein– ꢀl igandꢀdockingꢀprogramsꢀisꢀdifficult.ꢀProteins: Struct Funct
Bioinf.ꢀ2005;60(3):325- ꢀ3 32.
ꢀ
water- ꢀs olubleꢀdisulfonatedꢀtetrazoliumꢀsaltꢀasꢀaꢀchromogenicꢀindica-
tor for NADH as well as cell viability. Talanta.ꢀ1997;44(7):1299- ꢀ1 305.